Results 111 to 120 of about 1,471,694 (149)

Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management

MedComm, Volume 7, Issue 10, October 2026.
Colorectal cancer is a heterogeneous, adaptive disease shaped by population‐level risk, genomic and epigenetic alterations, tumor ecosystem evolution, and treatment pressure. This review integrates epidemiology, risk factors, signaling networks, clinical presentation, screening, molecular diagnosis, and stage‐ and biomarker‐guided management while ...
Kairui Wan, Ke Tang, Linglong Wang, Qin Tian, Mingwei Zheng, Cheng Qian, Limei Liu   +6 more
wiley   +1 more source

Diagnostic imaging of adnexal lesions in pregnancy: systematic review

Ultrasound in Obstetrics &Gynecology, Volume 68, Issue 4, Page 480-491, October 2026.
ABSTRACT Objective To describe the imaging features of adnexal lesions during pregnancy and assess the performance of current models for the risk assessment of such lesions. Methods This was a PROSPERO‐registered systematic review including studies published from inception to 1 August 2025 and was performed as per Preferred Reporting Systems for ...
N. Cooper, N. Kotecha, A. Novak, J. Barcroft, J. Yazbek, C. Landolfo, M. Al‐Memar, D. Timmerman, S. Saso, T. Bourne   +9 more
wiley   +1 more source

Differentiating high‐ and low‐grade serous ovarian carcinoma using radiomics: a pilot study

Ultrasound in Obstetrics &Gynecology, Volume 68, Issue 4, Page 559-570, October 2026.
ABSTRACT Objective To identify ultrasound‐based radiomics features capable of distinguishing between high‐grade serous ovarian carcinomas (HGSC) and invasive low‐grade serous ovarian carcinomas (LGSC), and to develop machine‐learning models that include radiomics features to discriminate between the two.
F. Ciccarone, G. Zinicola, E. H. Tran, G. Baldassari, E. Boccia, C. Nero, F. Moro, T. Pasciuto, G. Scambia, G. Ferrandina, A. Fagotti, A. C. Testa, D. Lorusso, Collaborators, F. Borella, F. Buonomo, R. Fruscio, F. Pozzati, R. Mancari   +18 more
wiley   +1 more source

Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

Frontiers in Oncology
ObjectiveTo determine the best possible value of pathological PCI (pPCI) as a prognostic marker for survival in high-grade serous epithelial ovarian cancer patients in patients treated with neoadjuvant chemotherapy and interval cytoreductive surgery ...
Snita Sinukumar, Dileep Damodaran, Deepika S., Sanjay Piplani   +3 more
doaj   +1 more source

Serial Cytoreductive Surgery and Survival Outcomes in Recurrent Adult-Type Ovarian Granulosa Cell Tumors [PDF]

BACKGROUND: Few studies have evaluated the role of cytoreductive surgery in patients with recurrent adult granulosa cell tumors of the ovary. Despite a multitude of treatment modalities in the recurrent setting, the optimal management strategy is not ...
Brodsky, Allison L, Lawson, Barrett, Legarreta, Alejandra Flores, Glassman, Deanna, Ramondetta, Lois M, How, Jeffrey A, Handley, Katelyn F, Hillman, R Tyler, Frumovitz, Michael, Foster, Katherine I, Westin, Shannon N, Fellman, Bryan, Gershenson, David M, Sood, Anil K, Vuttaradhi, Veena K   +14 more
core   +1 more source

Selective Depletion of Tumor‐Infiltrating CD4+CCR8+ Tregs by AZ084, a Novel CCR8 Antagonist

Cancer Science, Volume 117, Issue 10, Page 2719-2732, October 2026.
AZ084, a novel CCR8 antagonist, selectively targets tumor‐infiltrating CD4+CCR8+ Tregs, reduces their immunosuppressive function, and decreases IL‐10/TGF‐β production. ABSTRACT Regulatory T cells (Tregs) are key mediators of immunosuppression in ovarian cancer, yet strategies for selectively targeting tumor‐infiltrating Tregs remain limited.
Yepeng Mao, Ziqi Tao, Shuna Liu, Zhijie Liu, Yuelu Zhang, Lingfei Zhou, Lina Yan, Ting Wang, Wenwen Shang, Jianfang Lou, Xi Huang, Xin Fu, Fang Wang   +12 more
wiley   +1 more source

Predictive model for major complications after extensive abdominal surgery in primary advanced ovarian cancer

International Journal of Women's Health, 2019
Antoni Llueca,1–3 Anna Serra,1–3 Karina Maiocchi,2,4 Katty Delgado,2,5 Rosa Jativa,2,6 Luis Gomez,2,4 Javier Escrig3–5 On behalf of the MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery) 1Department of ...
Llueca A, Serra A, Maiocchi K, Delgado K, Jativa R, Gomez L, Escrig J   +6 more
doaj  

Case Report: Thoracoscopic secondary cytoreductive surgery for high-grade serous ovarian cancer

Frontiers in Surgery
The objective of this video is to show the feasibility of secondary cytoreductive surgery for recurrent high-grade serous ovarian cancer. The procedure targets recurrences in the cardiophrenic lymph nodes and the right diaphragm involving the right basal
Luigi Carlo Turco, Benedetta Alberghetti, Carlotta Francesca Cartia, Antonella Biscione, Giacomo Guidi, Giacomo Guidi, Filippo Maria Capomacchia, Andrea Droghetti   +7 more
doaj   +1 more source

Cytoreductive surgey and ovarian carcinoma

, 2009
Purpose of investigation:the aim of this study is to demostrate if cytoreductive surgery in patients with ovarian carcinoma increases overall ...
Antonietta Monteverde, Maria Amparo Manganaro, Ciro Franzese, BALBI, Giancarlo, Isabella Landino   +4 more
core  

Is complete cytoreductive surgery feasible in this patient with ovarian cancer?

, 2016
International audienceBackground Post-operative residual tumor size is the main prognostic factor in advanced epithelial ovarian cancer. Our objective was to develop a score for predicting the feasibility of complete cytoreductive surgery in patients ...
Dessapt, Anne Lucie, Bats, Anne Sophie, Huchon, Cyrille, Bensaid, Chérazade, Lecuru, Fabrice R., Ngo, Charlotte   +5 more
core   +1 more source